STAA - STAAR Surgical Co Enterprise Value

Stable demand for STAAR Surgical Company (STAA) products is driven by the integration of their lenses into surgical standards, transforming production into a high-margin asset. Market price action on GURU.Markets, where the enterprise value stands at 1120.08, confirms the success of EVO ICL biocompatible technologies as an alternative to laser vision correction. Business resilience is further bolstered by minimal staff turnover within the R&D sector and a strategic focus on expanding international distribution.

STAAR Surgical Company (STAA) expansion into Asian markets and its competition for the youth segment are reflected in the enterprise value dynamics. This indicator determines the theoretical buyout price of the company, accounting for all financial obligations. The calculation is based on the sum of market capitalization and net debt (total debt minus cash and cash equivalents). This metric allows for an assessment of the real value of assets without distortions from the capital structure. It is critical for investors to track this indicator to analyze whether the business is overbought.